Stocktoria

111, Inc. YI

Nasdaq · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2018-09-12 · LEI

111, Inc. financials (annual)

Revenue
$959.5M $259.8M $567.7M $1.26B $1.95B $1.96B $2.11B $1.97B $1.80B 201720182019202020212022202320242025
Net income
-$249.3M -$382.0M 201720182019202020212022202320242025
Free cash flow
-$211.2M -$52.0M -$76.5M -$21.8M -$117.9M -$7.9M -$64.4M $34.0M $16.4M 201720182019202020212022202320242025

Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$1.8B$2.0B$2.1B$2.0B$1.9B$1.3B$567.7M$259.8M$959.5M
Gross profit$723.4M$829.2M$849.0M$840.0M$621.1M$365.8M$165.2M$104.3M$80.5M
Operating income-$340,000$289,000-$49.3M-$53.8M-$100.8M-$72.5M-$70.9M-$58.2M-$254.0M
Interest expense$2.8M$1.9M$861,000$1.4M$520,000$55,000
Income tax$2,000$13,000$35,000$0$0$0$0$1,000
Net income-$382.0M-$249.3M
EPS (diluted)$-0.05$-0.05$-0.33$-0.36$-0.63$-2.77$-3.05
Operating cash flow$17.0M$36.0M-$63.0M-$3.4M-$108.1M-$17.9M-$73.6M-$49.9M-$204.4M
Free cash flow$16.4M$34.0M-$64.4M-$7.9M-$117.9M-$21.8M-$76.5M-$52.0M-$211.2M
Cash & equivalents$73.1M$63.3M$85.0M$97.7M$103.8M$182.3M$83.5M$124.2M$167.7M
Inventory$142.8M$190.1M$199.9M$217.3M$175.9M$117.5M$69.8M$30.7M$144.1M
Total assets$314.6M$381.9M$435.1M$503.7M$493.6M$463.8M$231.3M$224.9M$763.4M
Total liabilities$284.0M$329.8M$396.2M$409.7M$360.5M$259.9M$120.1M$46.9M$201.2M
Shareholders' equity-$103.2M-$90.2M-$83.8M-$60.1M-$27.2M$62.3M$111.6M$178.1M-$946.1M

Growth · year-over-year · Revenue CAGR 8.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth-9.0%-6.3%+7.4%+0.5%+55.1%+121.5%+118.5%-72.9%
Free cash flow growth-51.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.